The aim of our studies is to decipher the biological network that protects the genome from the deleterious action of 8-oxoG in eukaryotic cells. In
S. cerevisiae, this network involves at least four components: the 8-oxoG DNA
N-glycosylase (Ogg1), the Msh2–Msh6-dependent MMR, the Rad18–Rad6 complex and the DNA polymerase η (
26–28). Ogg1 is the major player and the only one able to remove 8-oxoG from DNA, which may explain why the contribution of other partners is unambiguously assessed only in Ogg1-deficient cells. Recently, we proposed a model (
28): (i) due to endogenous oxidative stress, 8-oxoG forms in genomic DNA, (ii) DNA polymerase δ in the presence of auxiliary proteins present at the replication fork efficiently incorporates adenine opposite to 8-oxoG, (iii) Msh2–Msh6 complex recognizes the A.8-oxoG pairs and initiates the MMR-dependent excision of the adenine paired with 8-oxoG, which results in the formation of a gapped-structure with 8-oxoG in a single-stranded DNA (ssDNA) region and (iv) During repair synthesis, the Rad18–Rad6 complex promotes the recruitment of Pol η, which incorporates a cytosine across from the lesion, preventing mutation fixation and regenerating the 8-oxoG.C pair substrate of Ogg1. Although attractive, this model presents a major caveat since it does not provide information about the molecular mechanisms that allow the specific recruitment of Pol η at the site of the lesion.
In the present study, we show that the
ogg1 pol30-K164R double mutant exhibits a synergistic increase in spontaneous Can
R mutation rate, compared to the single mutants. Our results unambiguously point to 8-oxoG as the primary cause for the high Can
R mutation rate in the
ogg1 pol30-K164R strain: (i) the spectrum of Can
R mutations in
ogg1 pol30-K164R is nearly exclusively composed of GC to TA and (ii) the high Can
R mutation rate in
ogg1 pol30-K164R is reduced to the WT level upon expression of the bacterial MutY protein. These data led us to conclude that modification of PCNA at lysine K164 is a critical component of the cellular network that prevents 8-oxoG-induced mutagenesis. In fact, the K164R mutation of PCNA abolishes the formation of all kinds of PCNA-Ub and greatly reduces that of PCNA-SUMO (
29,
30). Here, we show that neither
rad5 nor
siz1 synergizes with
ogg1, leading us to conclude that neither polyubiquitylated PCNA nor SUMO-PCNA is critical to prevent mutations at 8-oxoG. On the other hand, they strongly suggest that monoubiquitylation of PCNA (PCNA-Ub1) is essential.
Our genetic analysis points to the formation of PCNA-Ub1 in the course of the error free processing (TLS) of 8-oxoG. To investigate this issue at the biochemical level, we measured by western blotting the formation of PCNA-Ub in an
ogg1 deletion mutant. For comparison, we also tested an
apn1 apn2 mutant, unable to repair AP sites. Unfortunately, untreated
ogg1 cells do not exhibit detectable amounts of PCNA-Ub, like WT cells, which do not allow us to provide further information about the mechanisms of formation of PCNA-Ub1 during the processing of 8-oxoG. In contrast, untreated
apn1 apn2 cells present detectable level of PCNA-Ubn. These results may suggest that 8-oxoG does not efficiently stall replication forks, whereas the AP site does (
3). This is in favor of a model where PCNA-Ub1 forms during the gap-filling reaction after the MMR-dependent excision of adenine opposite to 8-oxoG. Indeed, this model relies on consistent but circumstantial evidence (
26–28) and its remains possible that the role of PCNA-Ub1 and Pol η also occurs at the stage of replication. The impact of 8-oxoG on DNA replication is also probably modulated by the sequence context around the lesion.
However, most
in vitro and
in vivo studies support the notion that the majority of the error-free TLS events at 8-oxoG occur in the course of a gap-filling reaction after MMR (
12–18,
26–28). MMR-dependent excision of adenine opposite to 8-oxoG results in the formation of stretches of ssDNA coated with RPA that might be used to activate Rad18–Rad6 and cause the formation of PCNA-Ub1 (
51). However, it is potentially deleterious (mutagenic) to trigger the formation of PCNA-Ub1 for the recruitment of Pol η during the repair synthesis after the processing of any mismatch subject to MMR (
52). To reconcile these two notions, one should conclude that 8-oxoG in ssDNA specifically initiates the molecular cascade that results in the formation of PCNA-Ub1. Clearly, we suggest that Pol δ efficiently bypasses 8-oxoG in ‘replication mode’, but may stall or pause at the same lesion in ‘gap-filling-repair mode’. It should be noted that purified Pol δ poorly replicates through 8-oxoG
in vitro showing two strong stall sites, one right before the lesion and the other opposite to the lesion (
27). In this model, Pol δ would initiate the gap-filling reaction and stall (pause) at 8-oxoG, thus allowing the recruitment of Rad18–Rad6 and the formation PCNA-Ub1.
Finally, Pol η binds to PCNA-Ub1 and catalyzes the incorporation of dCMP opposite to 8-oxoG. Here, we show that the UBZ of Pol η is essential to prevent 8-oxoG-induced mutagenesis, but only in conjunction with a functional PIP motif. This notion is based on the analysis of the properties of the D570A mutation in the UBZ domain of Pol η ( and ) (
37). However, this notion appeared to be at variance with the conclusions of another study reporting that mutations in the zinc-binding motif of the UBZ domain of Pol η such as CC552/553AA or HH568/572AA do not impair its TLS function
in vivo (
47), leading to the concept that the direct binding of the ubiquitin moiety on PCNA via the UBZ was not required for TLS by Pol η in
S. cerevisiae (
47). According to this study, the invalidation of the zinc-finger structure in the UBZ domain of Pol η should necessarily result in the loss of its ubiquitin-binding ability (
47). Here we show that Pol η -HH568/572AA not only exhibits functional TLS of 8-oxoG, but is also capable of productively interacting with the ubiquitin moiety of PCNA-Ub1, like the WT ( and 4). Even thought ubiquitin is not attached to its natural position (K164) on PCNA, our data strongly suggest that the zinc-finger structure of the UBZ domain of Pol η is not required for binding to the ubiquitin moiety of PCNA and hence for TLS in
S. cerevisiae. It should be noted that the presence of a Zn-finger structure in the UBZ domain of Pol η from
S. cerevisiae is not firmly demonstrated: (i) to the best of our knowledge, there is no structure of the UBZ domain of yeast Pol η (there is in fact one of the human UBZ domain, which does bind Zn) (
31) and (ii) the sequence is poorly conserved, since the two cysteines are contiguous in
S. cerevisiae (
CCKY) versus (
CEK
C) in the human protein. Indeed, we cannot exclude the possibility that Pol η's UBZ domain in
S. cerevisiae does not harbor any zinc at all, in analogy to the RING-like, but zinc-less U-box domain (
53). Taken together, our results are compatible with the hypothesis that points to an essential role of PCNA-Ub1 and its recognition by the UBZ and PIP domains of Pol η to prevent UVC- and 8-oxoG-induced mutagenesis in
S. cerevisiae. These conclusions may or may not be applicable to mammalian system where mutation in the Zn-finger of the UBZ domain of the human Pol η results in different phenotypes, since the H654A is TLS-deficient, whereas H650A is TLS-proficient (
54).
To summarize, our current model for the late steps of the error-free bypass of 8-oxoG is as follows: (i) Pol δ in the ‘gap-filling-repair’ mode transiently stalls at 8-oxoG, (ii) Rad18–Rad6 is recruited at RPA-coated ssDNA allowing the formation of PCNA-Ub1, (iii) Pol η through its UBZ and PIP domains binds to PCNA-Ub1, (iv) Pol η preferentially incorporates dCMP opposite to 8-oxoG, (v) PCNA is deubiquitylated allowing the release of Pol η. When one of the components of the fidelity system that favors the recruitment of Pol η is missing the equilibrium is shifted in favor of Pol δ, which will finally lead to the mutagenic incorporation of dAMP opposite to the lesion. In
S. cerevisiae, the complexity of the network orchestrated by Ogg1 points to 8-oxoG as a major cellular threat. In mammals, the inactivation of two major components of the network, that prevents mutation at 8-oxoG, namely Ogg1 and Myh1, results in a high incidence of cancer (
55).